Percy H. Carter, CHIEF SCIENTIFIC OFFICER at Blueprint Medicines Corp (BPMC), sold 5,077 shares at $127.88 ($649K) on 2025-06-03, disclosed to the SEC on 2025-06-05.
Seasonal sale ($649k) by CHIEF SCIENTIFIC OFFICER — this insider has traded BPMC in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $127.88 | 241 | $31K | 4.7% |
| 2 | $127.88 | 2,418 | $309K | 47.6% |
| 3 | $127.88 | 2,418 | $309K | 47.6% |
| Total | $127.88 avg | 5,077 | $649K | 100% |
| Filing → |
| BPMC | SELL | 2024-06-07 | $421K | — | Filing → |
| BPMC | SELL | 2024-06-05 | $519K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $415K | — | Filing → |